Rep. Tom Kean Jr. Returns to Congress After Nearly Four Months, Discloses Depression Diagnosis

New Jersey Republican Rep. Tom Kean Jr. returned to the House floor on June 30, 2026, ending an absence of nearly four months and publicly disclosing that depression had been the reason he was away, according to AP News and Maine Public/NPR. He made the disclosure in a speech on the House floor — a deliberate, public forum for a disclosure that many in his position have historically handled through carefully worded written statements, if at all.

During the period of his absence, the nature of his condition had gone unspecified. Fox News reported the condition had been described only as a medical issue, leaving his office, colleagues, and constituents without a clear account of when or whether he would return. That ambiguity stretched across roughly four months — a span long enough to raise substantive questions about constituent representation, committee obligations, and floor voting.

Mental health disclosures by sitting legislators remain uncommon, particularly on this timeline and in this format. Speaking from the House floor, rather than through a spokesperson or a written statement to local press, carries its own significance: it is a harder kind of transparency, done in the legislative chamber itself, before colleagues and the public record. Kean's decision to be explicit about a depression diagnosis — rather than characterizing his absence in vaguer clinical terms — places him in a small cohort of elected officials who have named the condition directly and on the record.

The political context matters here. Kean holds a competitive New Jersey district, and a four-month gap in visible representation is the kind of fact that resurfaces in campaign cycles. His floor speech preempts the narrative and, on its face, controls the terms of disclosure. Whether that transparency is met with political durability or vulnerability will depend largely on how his district processes the diagnosis — and how his office manages the legislative catch-up that a nearly four-month absence invariably requires.

There is also a broader institutional question, separate from Kean's individual case, about what extended member absences mean for a chamber that legislates by majority and where a single vote can be decisive. The House has no formal mechanism to compel medical disclosure or to temporarily fill a seat. That gap became visible during extended absences in recent Congresses, and Kean's case adds to the accumulating pressure — from advocacy groups and some members themselves — to revisit how the institution handles prolonged incapacity. None of that is resolved by one floor speech, but the speech gives the conversation a fresh data point.